Women's cardiovascular health: why menopause changes everything for your heart

When we think "heart attack", we still often picture a middle-aged man. Yet cardiovascular disease (heart attack, stroke, heart failure) is the leading cause of death in women worldwide. And if it strikes on average later than in men, that is no accident: until menopause, your body benefits from a form of hormonal protection. Then that protection fades. Menopause is not only a matter of hot flashes and disrupted sleep: it is also a quiet but decisive turning point for the health of your heart and your arteries. The good news is that this turning point is predictable, and therefore something you can get ahead of.

Why menopause is a turning point for your heart

Estrogen does not only regulate the menstrual cycle. It also has a protective effect on the cardiovascular system: it helps keep blood vessels supple, promotes their dilation, and contributes to maintaining a rather favourable lipid profile (the fats in the blood). When its production falls at menopause, this shield gradually withdraws. In 2020, the American Heart Association devoted an entire scientific statement to this subject, concluding that the menopausal transition constitutes a period of unfavourable cardiovascular changes and therefore represents a key window for acting early in prevention^[1].

In concrete terms, several things change at the same time around menopause: fat tends to redistribute towards the abdomen (the well-known visceral fat, more harmful metabolically than subcutaneous fat), blood pressure rises more easily, insulin sensitivity deteriorates, and the blood fat profile worsens^[1]. These changes are not due to ageing alone: they accelerate specifically at the time of the hormonal transition.

What actually changes in your blood

The best example concerns cholesterol. It was long believed that the rise in "bad" cholesterol in middle-aged women was simply linked to age. Yet the data from the large American SWAN study (Study of Women's Health Across the Nation) tell a more precise story. Following women around their final period, the researchers observed a clear increase in LDL cholesterol (the "bad" cholesterol) and in apolipoprotein B, a marker of the number of potentially atherogenic particles, in the window surrounding the final menstrual cycle^[2]. More important still: these rises were not harmless. The women in whom LDL and apoB rose the most around menopause subsequently showed more signs of early atherosclerosis in the carotid arteries (those that supply the brain)^[2]. In other words, what plays out in your blood work at this stage has measurable consequences for your arteries.

That is why a lipid panel and regular blood pressure measurement make full sense around the age of fifty. Not to dramatize, but because these are parameters that can be monitored and corrected, well before a problem arises.

Early menopause: a signal not to be overlooked

The moment when menopause occurs is not just a matter of the calendar: it says a great deal about cardiovascular risk. A vast analysis pooling the individual data of many international cohorts, published in The Lancet Public Health, showed that the earlier menopause occurs, the higher the risk of cardiovascular disease before 60^[3]. The link was particularly marked for stroke risk, greater in women who went through an early menopause than in those whose menopause came around the age of 50 to 51^[3].

The most notable case is that of premature ovarian insufficiency, that is, ovarian function stopping before the age of 40. A meta-analysis devoted to these women concluded that there was a significantly increased risk of cardiovascular events compared with women whose menopause came at a usual age^[4]. If you have gone through an early menopause, whether spontaneous, surgical (after removal of the ovaries) or following a treatment, that is important information to share with your doctor, because it may justify closer and earlier cardiovascular follow-up.

In women, the warning signs can be misleading

It is useful to know that the symptoms of a heart problem do not always show up in the "classic" way in women. Crushing chest pain radiating into the left arm does exist, but women also more frequently report less obvious signs: unusual breathlessness, intense and unexplained fatigue, pain in the back, the jaw or the stomach, nausea or cold sweats. Because these presentations are atypical, they are sometimes put down to stress, digestion or tiredness, delaying care. The message is not to worry about every sensation, but never to play down chest discomfort or sudden, unusual breathlessness: when in doubt, you should seek care without delay. And faced with intense or prolonged chest pain, sudden breathlessness or faintness, the right reflex in France is to call 15 (Samu), without waiting and without driving yourself.

What really protects your heart

Moving: the most solid lever

If only one action were to be remembered, it would be this one. A landmark study conducted in menopausal women as part of the Women's Health Initiative, published in the New England Journal of Medicine, brought a conclusion that is both reassuring and freeing: brisk walking was associated with a reduction in cardiovascular events comparable to that obtained with more vigorous exercise^[6]. In other words, there is no need to run a marathon: what counts is regularity and a moderate but sustained intensity. The most active women had a markedly lower cardiovascular risk than the most sedentary^[6]. Aiming for about 150 minutes of moderate activity a week (for example 30 minutes of brisk walking five times a week) remains an accessible and well-founded goal.

Watching your numbers and your lifestyle

Beyond physical activity, the fundamentals of prevention remain the same, but become more important after menopause. Having your blood pressure and lipid panel measured regularly makes it possible to detect a drift early and to act. Not smoking (tobacco cancels out a good part of vascular protection and worsens the risk), limiting alcohol, favouring a diet rich in vegetables, legumes, oily fish and olive oil and low in ultra-processed products, and preserving good-quality sleep: so many levers which, combined, make a real difference to heart health^[1]. None is spectacular taken on its own; it is their accumulation over time that protects.

This framework is not improvised. It is that of the European cardiovascular prevention guidelines of the European Society of Cardiology (ESC, 2021), which explicitly include female-specific situations, obstetric and non-obstetric, in risk assessment. In France, the French Society of Cardiology and the National Professional Cardiovascular Council published in May 2026 materials devoted to cardiovascular prevention in women, whose stated goal is precisely better identification of women's specific risk factors, earlier recognition of symptoms and stronger support in prevention. If you feel that your cardiovascular risk has never been assessed, that is an argument to put on the table at your next appointment.

And what about menopause hormone therapy?

This is a frequent and legitimate question. Let us be clear and honest: menopause hormone therapy (MHT) is not prescribed with the aim of preventing cardiovascular disease. A recent meta-analysis confirmed that its effect on the heart and vessels is nuanced and depends heavily on the context, in particular the woman's age and the time since menopause when the treatment is started^[5]. Started early, in a recently menopausal woman with no contraindication, the cardiovascular profile appears more favourable; started late, it may on the contrary carry risks (such as clots or stroke)^[5]. The decision about MHT is therefore made case by case, with a doctor, weighing symptoms, history and personal risk factors, and not as a treatment "for the heart".

The clinical practice recommendations of the CNGOF and GEMVi (2021) add two clarifications that matter for the heart and vessels. First the timing: the treatment is started after clinical confirmation of menopause, and not beyond ten years after its onset. Then the route of administration: they recommend favouring 17 beta-estradiol through the skin, better tolerated in terms of the lipid profile and insulin resistance than oral estrogen, the oral route being moreover associated with a higher thromboembolic risk than the transdermal route. Here too, that choice belongs to your doctor, not to an article.

What should be remembered, fundamentally, is that menopause is not a cardiovascular sentence. It is a moment when your body sends you a signal: precisely the opportunity to take back control. A check-up with your doctor, a few numbers to keep an eye on, a little more movement day to day: these simple actions, taken at the right time, are among the most effective for ageing in good cardiac health.

⚠️ This article is provided for informational and educational purposes only. It does not replace medical advice, diagnosis or treatment. Always consult your doctor or a qualified health professional with any questions about your health.

How we work: our editorial method · Written and verified by Bouchra, editorial lead.